# Ectoin® Mouth Wash (EML03) in the Prevention and Treatment of Radiation-induced Oral Mucositis

> **NCT03932292** · NA · COMPLETED · sponsor: **Bitop AG** · enrollment: 52 (actual)

## Conditions studied

- Oral Mucositis Due to Radiation

## Interventions

- **DRUG:** Ectoin Mouth Wash
- **DRUG:** Supersaturated solution of calcium and phosphate ions

## Key facts

- **NCT ID:** NCT03932292
- **Lead sponsor:** Bitop AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-18
- **Primary completion:** 2019-10-30
- **Final completion:** 2019-11-05
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2019-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932292, "Ectoin® Mouth Wash (EML03) in the Prevention and Treatment of Radiation-induced Oral Mucositis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03932292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*